194 related articles for article (PubMed ID: 29789544)
1. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations.
Sui T; Xu L; Lau YS; Liu D; Liu T; Gao Y; Lai L; Han R; Li Z
Cell Death Dis; 2018 May; 9(6):609. PubMed ID: 29789544
[TBL] [Abstract][Full Text] [Related]
2. Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits.
Thiruvengadam G; Sreetama SC; Charton K; Hogarth M; Novak JS; Suel-Petat L; Chandra G; Allard B; Richard I; Jaiswal JK
J Neuromuscul Dis; 2021; 8(s2):S243-S255. PubMed ID: 34633328
[TBL] [Abstract][Full Text] [Related]
3. A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide.
Xu J; Xu L; Lau YS; Gao Y; Moore SA; Han R
J Pathol Clin Res; 2018 Apr; 4(2):135-145. PubMed ID: 29665321
[TBL] [Abstract][Full Text] [Related]
4. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
[TBL] [Abstract][Full Text] [Related]
5. Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review.
Soontrapa P; Liewluck T
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292621
[TBL] [Abstract][Full Text] [Related]
6. Anoctamin 5 (ANO5) muscular dystrophy-three different phenotypes and a new histological pattern.
Seguí F; Gonzalez-Quereda L; Sanchez A; Matas-García A; Garrabou G; Rodriguez MJ; Gallano P; Grau JM; Milisenda JC
Neurol Sci; 2020 Oct; 41(10):2967-2971. PubMed ID: 32399949
[TBL] [Abstract][Full Text] [Related]
7. Anoctamin-5 Muscular Dystrophy: Report of Two Cases with Different Phenotypes and Genotypes from the Indian Subcontinent.
Mahajan S; Dhall A; Jassal B; Saluja A; Faruq M; Suri V; Rajan R; Vishnu VY; Sharma MC
Neurol India; 2022; 70(5):2169-2173. PubMed ID: 36352632
[TBL] [Abstract][Full Text] [Related]
8. Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy.
Xu J; El Refaey M; Xu L; Zhao L; Gao Y; Floyd K; Karaze T; Janssen PM; Han R
Skelet Muscle; 2015; 5():43. PubMed ID: 26693275
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5/TMEM16E-deficient patient muscle cells.
Chandra G; Defour A; Mamchoui K; Pandey K; Mishra S; Mouly V; Sreetama S; Mahad Ahmad M; Mahjneh I; Morizono H; Pattabiraman N; Menon AK; Jaiswal JK
Cell Death Discov; 2019; 5():118. PubMed ID: 31341644
[TBL] [Abstract][Full Text] [Related]
10. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.
Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K
Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264
[TBL] [Abstract][Full Text] [Related]
11. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
[TBL] [Abstract][Full Text] [Related]
12. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9.
Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865
[TBL] [Abstract][Full Text] [Related]
13. Limb girdle muscular dystrophy type 2L presenting as necrotizing myopathy.
Schneider I; Stoltenburg G; Deschauer M; Winterholler M; Hanisch F
Acta Myol; 2014 May; 33(1):19-21. PubMed ID: 24843231
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations.
Vázquez J; Lefeuvre C; Escobar RE; Luna Angulo AB; Miranda Duarte A; Delia Hernandez A; Brisset M; Carlier RY; Leturcq F; Durand-Canard MC; Nicolas G; Laforet P; Malfatti E
J Neuromuscul Dis; 2020; 7(4):443-451. PubMed ID: 32925086
[TBL] [Abstract][Full Text] [Related]
15. [Muscular dystrophy due to mutations in anoctamin 5: clinical and molecular genetic findings].
Deschauer M; Joshi PR; Gläser D; Hanisch F; Stoltenburg G; Zierz S
Nervenarzt; 2011 Dec; 82(12):1596-603. PubMed ID: 21739273
[TBL] [Abstract][Full Text] [Related]
16. ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure.
Jarmula A; Łusakowska A; Fichna JP; Topolewska M; Macias A; Johnson K; Töpf A; Straub V; Rosiak E; Szczepaniak K; Dunin-Horkawicz S; Maruszak A; Kaminska AM; Redowicz MJ
Sci Rep; 2019 Aug; 9(1):11533. PubMed ID: 31395899
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy.
Cai S; Gao M; Xi J; Liu Z; Yue D; Wu H; Bi H; Li J; Liang Z; Zhao C; Udd B; Luo S; Lu J
Neuromuscul Disord; 2019 Aug; 29(8):628-633. PubMed ID: 31350120
[TBL] [Abstract][Full Text] [Related]
18. Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression.
Witting N; Duno M; Petri H; Krag T; Bundgaard H; Kober L; Vissing J
J Neurol; 2013 Aug; 260(8):2084-93. PubMed ID: 23670307
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy.
Vihola A; Luque H; Savarese M; Penttilä S; Lindfors M; Leturcq F; Eymard B; Tasca G; Brais B; Conte T; Charton K; Richard I; Udd B
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):441-448. PubMed ID: 28489263
[TBL] [Abstract][Full Text] [Related]
20. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy.
Schessl J; Kress W; Schoser B
Muscle Nerve; 2012 May; 45(5):740-2. PubMed ID: 22499103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
